SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacob Snyder who wrote (501)5/21/2001 3:21:06 PM
From: scaram(o)uche  Read Replies (2) of 656
 
Did you learn anything from your little foray into SI-biotechland?

Mercks and AHPs the big winners? Certainly, they're going to generate the lion's share of revenues -- from new
products -- for the next decade or so. However, from a shareholder perspective, leverage comes from the biotech
sector. Further, some business plans are more highly leveraged than anything we've seen in the past. I again refer
you to NBIX.

You *do* like to make 110% in a couple of months, correct?

Alternatively, a little less dogma and you could have shuffled your friend into 80% on IMNX.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News